These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28941301)

  • 1. Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study.
    Maiwall R; Kumar A; Bhardwaj A; Kumar G; Bhadoria AS; Sarin SK
    Liver Int; 2018 Apr; 38(4):654-664. PubMed ID: 28941301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study.
    Maiwall R; Pasupuleti SSR; Bihari C; Rastogi A; Singh PK; Naik V; Singh A; Jain P; Kumar A; Mukund A; Mathur RP; Kumar G; Sarin SK
    Hepatology; 2020 Mar; 71(3):1009-1022. PubMed ID: 31313333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding.
    Hong C; Zhu Q; Li Y; Tang S; Lin S; Yang Y; Yuan S; Shao L; Wu Y; Liu B; Li B; Meng F; Chen Y; Hong M; Qi X
    Ren Fail; 2022 Dec; 44(1):398-406. PubMed ID: 35225149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
    Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
    J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
    Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
    Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
    Zappitelli M; Greenberg JH; Coca SG; Krawczeski CD; Li S; Thiessen-Philbrook HR; Bennett MR; Devarajan P; Parikh CR;
    JAMA Pediatr; 2015 Jun; 169(6):583-91. PubMed ID: 25844892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early serum cystatin C-enhanced risk prediction for acute kidney injury post cardiac surgery: a prospective, observational, cohort study.
    Wang X; Lin X; Xie B; Huang R; Yan Y; Liu S; Zhu M; Lu R; Qian J; Ni Z; Xue S; Che M
    Biomarkers; 2020 Feb; 25(1):20-26. PubMed ID: 31686541
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.
    Lau L; Al-Ismaili Z; Harel-Sterling M; Pizzi M; Caldwell JS; Piccioni M; Lands LC; Mottes T; Devarajan P; Goldstein SL; Bennett MR; Zappitelli M
    Pediatr Nephrol; 2017 Jan; 32(1):163-171. PubMed ID: 27743042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle change of cystatin C, with or without acute kidney injury, associated with increased mortality in the intensive care unit.
    Kwon SH; Hyun J; Jeon JS; Noh H; Han DC
    J Crit Care; 2011 Dec; 26(6):566-71. PubMed ID: 21419594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.
    Bai Z; Fang F; Xu Z; Lu C; Wang X; Chen J; Pan J; Wang J; Li Y
    BMC Pediatr; 2018 Jun; 18(1):192. PubMed ID: 29907141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis.
    Jo SK; Yang J; Hwang SM; Lee MS; Park SH
    Sci Rep; 2019 Oct; 9(1):14508. PubMed ID: 31601879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis.
    Vijay P; Lal BB; Sood V; Khanna R; Alam S
    Eur J Pediatr; 2021 Nov; 180(11):3287-3295. PubMed ID: 33978827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.
    Jha P; Jha AK; Dayal VM; Jha SK; Kumar A
    Indian J Gastroenterol; 2021 Dec; 40(6):563-571. PubMed ID: 34981441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
    Allegretti AS; Ortiz G; Kalim S; Wibecan J; Zhang D; Shan HY; Xu D; Chung RT; Karumanchi SA; Thadhani RI
    Dig Dis Sci; 2016 Dec; 61(12):3609-3620. PubMed ID: 27655105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.
    Wan ZH; Wang JJ; You SL; Liu HL; Zhu B; Zang H; Li C; Chen J; Xin SJ
    World J Gastroenterol; 2013 Dec; 19(48):9432-8. PubMed ID: 24409073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
    Lagos-Arevalo P; Palijan A; Vertullo L; Devarajan P; Bennett MR; Sabbisetti V; Bonventre JV; Ma Q; Gottesman RD; Zappitelli M
    Pediatr Nephrol; 2015 Apr; 30(4):665-76. PubMed ID: 25475610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C as an early marker of acute kidney injury and predictor of mortality in the intensive care unit after acute myocardial infarction.
    Fouad M; Boraie M
    Arab J Nephrol Transplant; 2013 Jan; 6(1):21-6. PubMed ID: 23282229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.
    Leem AY; Park MS; Park BH; Jung WJ; Chung KS; Kim SY; Kim EY; Jung JY; Kang YA; Kim YS; Kim SK; Chang J; Song JH
    Yonsei Med J; 2017 May; 58(3):604-612. PubMed ID: 28332367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.